GR3018798T3 - Pyrrolo [2,1-b]thiazole derivatives - Google Patents

Pyrrolo [2,1-b]thiazole derivatives

Info

Publication number
GR3018798T3
GR3018798T3 GR960400186T GR960400186T GR3018798T3 GR 3018798 T3 GR3018798 T3 GR 3018798T3 GR 960400186 T GR960400186 T GR 960400186T GR 960400186 T GR960400186 T GR 960400186T GR 3018798 T3 GR3018798 T3 GR 3018798T3
Authority
GR
Greece
Prior art keywords
group
substituents
alkyl group
moiety
aryl group
Prior art date
Application number
GR960400186T
Other languages
English (en)
Inventor
Norio Suzuki
Atsushi Nakayama
Toru Hosokami
Masashi Hasegawa
Shuichi Yokohama
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of GR3018798T3 publication Critical patent/GR3018798T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Detergent Compositions (AREA)
GR960400186T 1989-06-13 1996-01-25 Pyrrolo [2,1-b]thiazole derivatives GR3018798T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15114189 1989-06-13

Publications (1)

Publication Number Publication Date
GR3018798T3 true GR3018798T3 (en) 1996-04-30

Family

ID=15512262

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400186T GR3018798T3 (en) 1989-06-13 1996-01-25 Pyrrolo [2,1-b]thiazole derivatives

Country Status (23)

Country Link
US (1) US5098919A (el)
EP (1) EP0410224B1 (el)
JP (1) JP2875605B2 (el)
KR (1) KR910002874A (el)
CN (1) CN1025337C (el)
AT (1) ATE132870T1 (el)
AU (1) AU624724B2 (el)
CA (1) CA2021135A1 (el)
DD (1) DD296492A5 (el)
DE (1) DE69024713T2 (el)
DK (1) DK0410224T3 (el)
ES (1) ES2084622T3 (el)
FI (1) FI903511A0 (el)
GR (1) GR3018798T3 (el)
HU (1) HU207331B (el)
IE (1) IE902545A1 (el)
IL (1) IL95021A (el)
NO (1) NO903084L (el)
NZ (1) NZ234450A (el)
PT (1) PT94688A (el)
RU (2) RU1836374C (el)
YU (1) YU136490A (el)
ZA (1) ZA905407B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244892A1 (en) * 2004-02-27 2005-11-03 Lazar Mitchell A Resistin as a marker and therapeutic target for cardiovascular disease
CN107402307A (zh) * 2008-04-09 2017-11-28 B.R.A.H.M.S 有限公司 用于预测受损峰值耗氧量的内皮素1原

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193926A (en) * 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
US4347186A (en) * 1980-10-20 1982-08-31 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein

Also Published As

Publication number Publication date
US5098919A (en) 1992-03-24
HU904214D0 (en) 1990-12-28
IL95021A (en) 1994-06-24
NO903084L (no) 1991-01-14
JP2875605B2 (ja) 1999-03-31
ATE132870T1 (de) 1996-01-15
DE69024713T2 (de) 1996-06-13
YU136490A (sh) 1992-09-07
PT94688A (pt) 1991-03-20
FI903511A0 (fi) 1990-07-11
CN1025337C (zh) 1994-07-06
CA2021135A1 (en) 1991-01-14
RU2026288C1 (ru) 1995-01-09
DK0410224T3 (da) 1996-02-05
EP0410224A1 (en) 1991-01-30
NO903084D0 (no) 1990-07-11
IE902545A1 (en) 1991-02-27
DE69024713D1 (de) 1996-02-22
ZA905407B (en) 1991-04-24
IL95021A0 (en) 1991-06-10
KR910002874A (ko) 1991-02-26
AU5890490A (en) 1991-01-17
NZ234450A (en) 1991-10-25
CN1049350A (zh) 1991-02-20
RU1836374C (ru) 1993-08-23
AU624724B2 (en) 1992-06-18
HU207331B (en) 1993-03-29
ES2084622T3 (es) 1996-05-16
HUT57221A (en) 1991-11-28
EP0410224B1 (en) 1996-01-10
JPH03128385A (ja) 1991-05-31
DD296492A5 (de) 1991-12-05

Similar Documents

Publication Publication Date Title
FI906204A (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
NO912805L (no) Fremgangsmaate for fremstilling av pyrazolopyridin-forbindelser.
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
AU3309489A (en) 2-alkyl-3-benzoylbenzofurans and pharmaceutical compositions containing them
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
IL85768A0 (en) Benzoxazine derivatives,their preparation and pharmaceutical compositions containing them
IL75987A0 (en) 1,6-naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
AU624724B2 (en) Pyrrolo(2,1-b)thiazole derivatives
ATE146476T1 (de) Cephalosporinverbindungen und verfahren zu ihrer herstellung
AU8003594A (en) Quinolinecarboxylic acid derivative and salt thereof
HU913293D0 (en) Process for the production of pierazine derivatives and medical preparations containing them
AU8292787A (en) Fluorine-containing macrolide compounds and their use